Literature DB >> 18833216

McArdle disease: what do neurologists need to know?

Alejandro Lucia1, Gisela Nogales-Gadea, Margarita Pérez, Miguel A Martín, Antoni L Andreu, Joaquín Arenas.   

Abstract

McArdle disease (also known as glycogen storage disease type V) is a pure myopathy caused by an inherited deficit of myophosphorylase, the skeletal muscle isoform of the enzyme glycogen phosphorylase. The disease exhibits clinical heterogeneity, but patients typically experience exercise intolerance, that is, reversible, acute crises (early fatigue and contractures, sometimes with rhabdomyolysis and myoglobinuria) triggered by static muscle contractions (e.g. lifting weights) or dynamic exercise (e.g. climbing stairs or running). In this Review, we discuss the main features of McArdle disease, with the aim of providing neurologists with up-to-date, useful information to assist their patients. The topics covered include diagnostic tools-for example, molecular genetic diagnosis, the classic ischemic forearm test and the so-called 'second wind' phenomenon-and current therapeutic options-for example, a carbohydrate-rich diet and carbohydrate ingestion shortly before strenuous exercise, in combination with medically supervised aerobic training of low to moderate intensity.

Entities:  

Mesh:

Year:  2008        PMID: 18833216     DOI: 10.1038/ncpneuro0913

Source DB:  PubMed          Journal:  Nat Clin Pract Neurol        ISSN: 1745-834X


  47 in total

1.  Phenotype consequences of myophosphorylase dysfunction: insights from the McArdle mouse model.

Authors:  Astrid Brull; Noemí de Luna; Albert Blanco-Grau; Alejandro Lucia; Miguel Angel Martin; Joaquin Arenas; Ramon Martí; Antoni L Andreu; Tomàs Pinós
Journal:  J Physiol       Date:  2015-05-18       Impact factor: 5.182

2.  Muscle molecular adaptations to endurance exercise training are conditioned by glycogen availability: a proteomics-based analysis in the McArdle mouse model.

Authors:  Carmen Fiuza-Luces; Alejandro Santos-Lozano; Francisco Llavero; Rocío Campo; Gisela Nogales-Gadea; Jorge Díez-Bermejo; Carlos Baladrón; África González-Murillo; Joaquín Arenas; Miguel A Martín; Antoni L Andreu; Tomàs Pinós; Beatriz G Gálvez; Juan A López; Jesús Vázquez; José L Zugaza; Alejandro Lucia
Journal:  J Physiol       Date:  2018-02-14       Impact factor: 5.182

Review 3.  Gene therapy for glycogen storage diseases.

Authors:  Priya S Kishnani; Baodong Sun; Dwight D Koeberl
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

Review 4.  McArdle disease: a unique study model in sports medicine.

Authors:  Alfredo Santalla; Gisela Nogales-Gadea; Niels Ørtenblad; Astrid Brull; Noemi de Luna; Tomàs Pinós; Alejandro Lucia
Journal:  Sports Med       Date:  2014-11       Impact factor: 11.136

Review 5.  Rhabdomyolysis: pathogenesis of renal injury and management.

Authors:  Zubaida Al-Ismaili; Melissa Piccioni; Michael Zappitelli
Journal:  Pediatr Nephrol       Date:  2011-01-20       Impact factor: 3.714

Review 6.  Neuromuscular disorders of glycogen metabolism.

Authors:  Elisabetta Gazzerro; Antoni L Andreu; Claudio Bruno
Journal:  Curr Neurol Neurosci Rep       Date:  2013-03       Impact factor: 5.081

7.  McArdle disease: a "pediatric" disorder presenting in an adult with acute kidney injury.

Authors:  Xixi Zhao; Angela Li; Madhu Soni; Michael J Muriello; Carolyn H Jones; William L Whittier
Journal:  CEN Case Rep       Date:  2017-06-28

Review 8.  Myositis Mimics.

Authors:  E Harlan Michelle; Andrew L Mammen
Journal:  Curr Rheumatol Rep       Date:  2015-10       Impact factor: 4.592

9.  Comparative gene expression profiling between human cultured myotubes and skeletal muscle tissue.

Authors:  Frederic Raymond; Sylviane Métairon; Martin Kussmann; Jaume Colomer; Andres Nascimento; Emma Mormeneo; Cèlia García-Martínez; Anna M Gómez-Foix
Journal:  BMC Genomics       Date:  2010-02-22       Impact factor: 3.969

10.  Clinical utility gene card for McArdle disease.

Authors:  Rhonda L Taylor; Mark Davis; Emma Turner; Astrid Brull; Tomás Pinos; Macarena Cabrera; Kristen J Nowak
Journal:  Eur J Hum Genet       Date:  2018-01-25       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.